Siemens Healthineers announces first global installation of the Acuson Sequoia ultrasound system

Siemens Healthineers has announced the first global installation of its newest ultrasound system, the Acuson Sequoia, at Baptist Health South Florida. With ten facilities and five “centers of excellence” in the South Florida region, Baptist Health South Florida purchased numerous Acuson Sequoia systems in order to enhance its imaging capabilities within the scope of gastroenterology, primary care, and bariatric specialties. With its powerful architecture and innovative features, the new Acuson Sequoia expands precision medicine by enabling high-resolution imaging that adapts to patients’ size and personal physical characteristics, contributing to more confident diagnosis.

“The Acuson Sequoia enables our customers to image patients, regardless of size or body composition, with consistency and clarity,” says David Pacitti, President and Head of the Americas for Siemens Healthineers. “Without sacrificing image quality and potentially reducing the need for repeat scans and unclear diagnoses, the Acuson Sequoia will allow Baptist Health South Florida to underscore its commitment to clinical and service excellence in its community by improving the experiences of the patients it serves.”

Siemens Healthineers built the entirely new Acuson Sequoia system to adapt to the “BioAcoustic Variations” of each patient, characteristics that include tissue density, stiffness, and absorption. With its new Deep Abdominal Transducer (DAX), a new high-powered architecture, and innovative updates to elastography and contrast-enhanced ultrasound, the new Acuson Sequoia produces penetration up to 40cm without image quality degradation often caused by attenuating echo signals, an industry first.

Around the web

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.